Pfizer Inc
NYSE: PFE
$26.01
+$0.36 (+1.4%)
Real Time Data Delayed 15 Min.
PFE Articles
Gene therapy may become the next frontier for drug companies seeking to make billions of dollars improving or even curing certain diseases.
Published:
Last Updated:
Pfizer is looking to collaborate with Vivet on the development of its proprietary treatment for Wilson disease.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
Judging by the most shorted stocks traded on the New York Stock Exchange between the February 15 and February 28 settlement dates, those sellers were cautious overall, as moves were mixed and...
Published:
Last Updated:
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Judging by the most shorted stocks traded on the New York Stock Exchange between the January 31 and February 15 settlement dates, those sellers were shifting priorities, as moves were mixed with some...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen for Monday included Allscripts Healthcare Solutions, AmeriGas Partners, CVS Health, IMAX, Kraft Heinz, Marathon Oil, Microsoft and Pfizer.
Published:
Last Updated:
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
There are many stocks that are targeted toward mature adults and seniors or that offer classical investing themes for those who are retired now or are within a decade of retiring.
Published:
Last Updated:
These four solid companies have released good earnings and pay consistent and healthy dividends. All make more sense going forward for investors getting a little nervous about what the rest of 2019...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell, ServiceNow and Tiffany.
Published:
Last Updated:
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,...
Published:
Last Updated:
Pfizer released better-than-expected fourth-quarter financial results and guidance before the markets opened on Tuesday.
Published:
Last Updated:
Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest year-over-year growth.
Published:
Last Updated:
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated: